Can-Fite BioPharma American Depositary Shares
CANF
9 hedge funds and large institutions have $638K invested in Can-Fite BioPharma American Depositary Shares in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.
256% more capital invested
Capital invested by funds: $179K → $638K (+$459K)
0% more funds holding
Funds holding: 9 → 9 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$332K |
| 2 |
Morgan Stanley
New York
|
+$128K |
| 3 |
SIA
Schechter Investment Advisors
Birmingham,
Michigan
|
+$43.2K |
| 4 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$1.2K |
| 5 |
SHIM
Stone House Investment Management
Tunkhannock,
Pennsylvania
|
+$1.03K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$31.9K |
| 2 |
JP Morgan Chase
New York
|
-$1.22K |
| 3 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$140 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $340K | +$332K | +7,718 | New |
|
|
2
Morgan Stanley
New York
| $204K | +$128K | +2,977 | +180% |
|
|
SIA
3
Schechter Investment Advisors
Birmingham,
Michigan
| $44.2K | +$43.2K | +1,004 | New |
|
|
4
RhumbLine Advisers
Boston,
Massachusetts
| $40.7K | +$1.2K | +28 | +3% |
|
5
Fifth Third Bancorp
Cincinnati,
Ohio
| $6.6K | – | – | – |
|
6
National Bank of Canada
Montreal,
Quebec, Canada
| $1.24K | – | – | – |
|
7
Citigroup
New York
| $1.22K | – | – | – |
|
|
SHIM
8
Stone House Investment Management
Tunkhannock,
Pennsylvania
| $1.03K | +$1.03K | +24 | New |
|
|
TWC
9
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $54 | – | – | – |
|
|
10
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$31.9K | -602 | Closed |
|
|
11
JP Morgan Chase
New York
| – | -$1.22K | -23 | Closed |
|
|
FDCDDQ
12
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| – | -$140 | -3 | Closed |
|
CANF Hedge Fund Activity: Q4 2023 in Review
9 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Can-Fite BioPharma American Depositary Shares (CANF) for Q4 2023, worth a combined $638K — up 256% from $179K a quarter earlier.
Fund positioning in CANF was balanced in Q4 2023: 3 funds opened new positions, 3 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $332K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $31.9K sold.
- 9 institutional investors held Can-Fite BioPharma American Depositary Shares (CANF) as of Q4 2023, unchanged from Q3 2023.
- Funds reported $638K of Can-Fite BioPharma American Depositary Shares stock for Q4 2023, up 256% quarter-over-quarter.
- 3 funds opened new Can-Fite BioPharma American Depositary Shares positions in Q4 2023 and 3 closed out, a net change of 0 holders.
- The largest Can-Fite BioPharma American Depositary Shares buyer in Q4 2023 was Armistice Capital, an estimated $332K added.
- The largest Can-Fite BioPharma American Depositary Shares seller in Q4 2023 was Susquehanna International Group, an estimated $31.9K sold.
Based on aggregated 13F filings for Q4 2023.